Belgium· BE-AMP-SAM548284-00
Slinda 4 mg
A drospirenone product containing placebo, registered in Belgium by Exeltis Germany. The same ATC class is registered in 13 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Drospirenone is registered in 13 of 19 countries.
Countries holding a registration under ATC G03AC10 (drospirenone), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 8 of them publish a price we can compare per daily dose
Drospirenone · ATC G03AC10
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Placebo
- Manufacturer
- Exeltis Germany
- Country
- Belgium (BE)
- ATC code
- G03AC10
- ATC class
- Drospirenone
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 4
- be_apb4638896
- be_apb7727415
- be_apb4135224
- be_apb4135216
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
172 interactions on record for drospirenone.
Graded by severity as the source publishes them — 27 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Drospirenone · interactions on record
172 records
- 27 severe
- 143 moderate
- 2 minor
Most severe, free to view
- Tranexamic acidB02AA02severe
- GriseofulvinD01AA08severe
- GriseofulvinD01BA01severe
- KetoconazoleH02CA03severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Drospirenone in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- GermanyP-Tabletten Weiß 7 Mm LichtensteinWinthrop Arzneimittel Gmbh
- NorwayPlacebo SASykehusapotekene HF
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Germany · P-Tabletten Weiß 7 Mm Lichtenstein
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c976c802-2df7-4186-9318-cb49f960e1f6 GET /v1/drugs/c976c802-2df7-4186-9318-cb49f960e1f6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Slinda 4 mg",
"name_fr": "Slinda 4 mg",
"name_nl": "Slinda 4 mg",
"amp_code": "SAM548284-00",
"strengths": [
"55.5000",
"0.0300",
"4.0000",
"17.5000"
],
"pack_count": 4,
"substances": [
"Placebo",
"Lactose Monohydrate",
"Polysorbate 80",
"Drospirenone",
"Lactose"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Drospirenone",
"authorisation_numbers": [
"BE548284"
]
}See everything about drospirenone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.